Crinetics Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Crinetics Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2023.
  • Crinetics Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $11M, a 336% increase year-over-year.
  • Crinetics Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $33.5M, a 269% increase year-over-year.
  • Crinetics Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $13.3M, a 167% increase from 2022.
  • Crinetics Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $4.97M, a 8054% increase from 2021.
  • Crinetics Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $61K, a 94.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $13.3M +$8.3M +167% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $4.97M +$4.91M +8054% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $61K -$1.08M -94.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $1.14M -$2.27M -66.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $3.41M +$1.82M +114% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
2018 $1.6M +$1.63M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
2017 -$30K -$55K -220% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-09
2016 $25K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.